Concepedia

Author

Hrishikesh Kale

Pharmerit (United States)ORCID

Also Known As

H Kale, H. Kale, Hrishikesh Kale, Hrishikesh P Kale, Hrishikesh P. Kale, Kale, Hrishikesh

39

Publications

722

Citations

10

H-Index

17

Concepts

All Affiliations

Pharmerit (United States)Virginia Commonwealth UniversityUniversity of PennsylvaniaYale Cancer CenterTaiho Oncology (United States)
HK

About

Hrishikesh Kale is an author at Pharmerit (United States) specializing in health sciences, geriatric oncology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Health Sciences

2

2

34

2

Engineering

1

1

18

3

Medicine

1

1

16

4

Geriatrics

1

1

16

5

Kinesiology

1

1

18

Hrishikesh Kale

×

10

Publications

688

Citations

10

H-Index

YearCitations

Self‐reported financial burden of cancer care and its effect on physical and mental health‐related quality of life among US cancer survivors

Hrishikesh Kale, Norman V. Carroll

Cancer

2016

345

Changes in oxycodone and heroin exposures in the National Poison Data System after introduction of extended‐release oxycodone with abuse‐deterrent characteristics

Paul Coplan, Hrishikesh Kale, Lauren Sandstrom,

Pharmacoepidemiology and Drug Safety

2013

124

Reductions in reported deaths following the introduction of extended‐release oxycodone (OxyContin) with an abuse‐deterrent formulation

Nelson E. Sessler, Jerod M. Downing, Hrishikesh Kale,

Pharmacoepidemiology and Drug Safety

2014

84

Assessment of Rates of Acute Adverse Reactions to Gadobenate Dimeglumine: Review of More Than 130,000 Administrations in 7.5 Years

Saeed Fakhran, Lea Alhilali, Hrishikesh Kale,

American Journal of Roentgenology

2015

35

Under-use of Hypomethylating Agents in Patients With Higher-risk Myelodysplastic Syndrome in the United States: A Large Population-based Analysis

Shelby Corman, Namita Joshi, Tim Wert,

Clinical Lymphoma Myeloma & Leukemia

2020

24

Human Posture Recognition using Artificial Neural Networks

Hrishikesh Kale, Prathamesh Mandke, Hrishikesh Mahajan,

2018

18

Survival, costs, and health care resource use by line of therapy in US Medicare patients with newly diagnosed glioblastoma: a retrospective observational study

Abdalla Aly, Prianka Singh, Beata Korytowsky,

Neuro-Oncology Practice

2019

17

Economic burden of renal cell carcinoma among older adults in the targeted therapy era

Hrishikesh Kale, Darcy P. Mays, Pramit Nadpara,

Urologic Oncology Seminars and Original Investigations

2019

16

A Comparison of Pharmacy Dispensing Channel Use and Adherence to Specialty Drugs Among Medicare Part D Beneficiaries

Hrishikesh Kale, Anisha M. Patel, Norman V. Carroll

Journal of Managed Care & Specialty Pharmacy

2018

14

Direct Medical Costs Associated With Treatment Nonpersistence in Patients With Higher-Risk Myelodysplastic Syndromes Receiving Hypomethylating Agents: A Large Retrospective Cohort Analysis

Namita Joshi, Hrishikesh Kale, Shelby Corman,

Clinical Lymphoma Myeloma & Leukemia

2020

11

Page 1